MERONI, MARICA
MERONI, MARICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study]
2021 M. Longo, E. Paolini, M. Meroni, L. Duca, I. Motta, A.L. Fracanzani, E. Di Pierro, P. Dongiovanni
Alcohol or gut microbiota : who is the guilty?
2019 M. Meroni, M. Longo, P. Dongiovanni
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH
2023 M.P. Moore, X. Wang, H. Shi, M. Meroni, A. Cherubini, L. Ronzoni, E.J. Parks, J.A. Ibdah, R.S. Rector, L. Valenti, P. Dongiovanni, I. Tabas
DOWN-REGULATION OF HEPATIC MBOAT7 BY HYPERINSULINEMIA FAVORS STEATOSIS DEVELOPMENT
2018 M. Meroni
Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
2022 M. Meroni, M. Longo, E. Paolini, G. Tria, M. Ripolone, L. Napoli, M. Moggio, A.L. Fracanzani, P. Dongiovanni
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease
2017 S. Petta, L. Valenti, G. Svegliati Baroni, M. Ruscica, R.M. Pipitone, P. Dongiovanni, C. Rychlicki, N. Ferri, C. Cammà, A.L. Fracanzani, I. Pierantonelli, V. Di Marco, M. Meroni, D. Giordano, S. Grimaudo, M. Maggioni, D. Cabibi, S. Fargion, A. Craxì
From Environment to Genome and Back : a Lesson from HFE Mutations
2020 R. Rametta, M. Meroni, P. Dongiovanni
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease
2020 M. Meroni, M. Longo, P. Dongiovanni
Genetics is of the essence to face NAFLD
2021 M. Meroni, M. Longo, G. Tria, P. Dongiovanni
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort
2020 Q.M. Anstee, R. Darlay, S. Cockell, M. Meroni, O. Govaere, D. Tiniakos, A.D. Burt, P. Bedossa, J. Palmer, Y. Liu, G.P. Aithal, M. Allison, H. Yki-Järvinen, M. Vacca, J. Dufour, P. Invernizzi, D. Prati, M. Ekstedt, S. Kechagias, S. Francque, S. Petta, E. Bugianesi, K. Clement, V. Ratziu, J.M. Schattenberg, L. Valenti, C.P. Day, H.J. Cordell, A.K. Daly
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b
2022 S.J. Patel, N. Liu, S. Piaker, A. Gulko, M.L. Andrade, F.D. Heyward, T. Sermersheim, N. Edinger, H. Srinivasan, M.P. Emont, G.P. Westcott, J. Luther, R.T. Chung, S. Yan, M. Kumari, R. Thomas, Y. Deleye, A. Tchernof, P.J. White, G.A. Baselli, M. Meroni, D.F. De Jesus, R. Ahmad, R.N. Kulkarni, L. Valenti, L. Tsai, E.D. Rosen
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
2018 C. Zhu, K. Kim, X. Wang, A. Bartolome, M. Salomao, P. Dongiovanni, M. Meroni, M.J. Graham, K.P. Yates, A.M. Diehl, R.F. Schwabe, I. Tabas, L. Valenti, J.E. Lavine, U.B. Pajvani
Impact of natural neuromedin-B receptor variants on iron metabolism
2020 R. Rametta, P. Dongiovanni, G.A. Baselli, S. Pelusi, M. Meroni, A.L. Fracanzani, F. Busti, A. Castagna, S. Scarlini, E. Corradini, A. Pietrangelo, D. Girelli, S. Fargion, L. Valenti
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
2022 A. Cespiati, M. Meroni, R. Lombardi, G. Oberti, P. Dongiovanni, A.L. Fracanzani
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease
2017 P. Dongiovanni, M. Meroni, G.A. Baselli, G.A. Bassani, R. Rametta, A. Pietrelli, M. Maggioni, F. Facciotti, V. Trunzo, S. Badiali, S. Fargion, S. Gatti, L.V.C. Valenti
Liver fat accumulation is associated with circulating PCSK9
2016 M. Ruscica, N. Ferri, C. Macchi, M. Meroni, C. Lanti, C. Ricci, M. Maggioni, A.L. Fracanzani, S. Badiali, S. Fargion, P. Magni, L. Valenti, P. Dongiovanni
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker
2020 G.A. Baselli, P. Dongiovanni, R. Rametta, M. Meroni, S. Pelusi, M. Maggioni, S. Badiali, P. Pingitore, S. Maurotti, T. Montalcini, A.E. Taliento, D. Prati, G. Rossi, A.L. Fracanzani, R.M. Mancina, S. Romeo, L. Valenti
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
2020 B. Cai, P. Dongiovanni, K.E. Corey, X. Wang, I.O. Shmarakov, Z. Zheng, C. Kasikara, V. Davra, M. Meroni, R.T. Chung, C.V. Rothlin, R.F. Schwabe, W.S. Blaner, R.B. Birge, L. Valenti, I. Tabas
MAFLD in COVID-19 patients: an insidious enemy
2020 P. Dongiovanni, M. Meroni, M. Longo, A.L. Fracanzani
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD
2020 M. Meroni, M. Longo, A.L. Fracanzani, P. Dongiovanni